foxo4-dri human clinical trial Frontiers FOXO4-DRI 10mg : Research Only

A 5 mg vial reconstituted with bacteriostatic water yields about 1.67 mg/mL

As BPC-157 is specifically banned by the WADA it is banned by the WNBF as well

The clinical use of Dihexa in wellness and longevity settings is based on the preclinical evidence combined with growing clinical observation from providers who prescribe it off-label

Every Janoshik COA includes a verification key that resolves at janoshikanalytical.com, so researchers can confirm the certificate's authenticity without trusting the supplier's word alone

It moves offshore (particularly to China) and into black market channels, with no prescriber oversight, no lot testing, and no accountability to anyone

It is a cell-building protein that is essential in forming cellular structures when repairing and regenerating damaged tissue